Skip to content

Evaluation Study of a Formulation on Aging-Related Skin Parameters

Evaluation Study of a Formulation on Aging-Related Skin Parameters - Evaluation Study of a Formulation on Aging-Related Skin Parameters

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000060768
Enrollment
30
Registered
2026-02-28
Start date
2026-03-02
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

topical test product.The topical test product will be applied to one side of the face for 8 weeks. The placebo product will be applied to the contralateral side of the face.

Sponsors

Rohto Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Subjects meeting all of the following criteria will be included: 1. Healthy Japanese females aged 30 to 60 years at the time of informed consent 2. Subjects who are able to understand the study procedures and provide written informed consent 3. Subjects who are able to use the investigational product as instructed during the study period 4. Subjects who have subjective awareness of facial redness

Exclusion criteria

Exclusion criteria: Subjects meeting any of the following criteria will be excluded: 1. Subjects with any dermatological condition at the study site or systemic condition that may affect study evaluation 2. Subjects with a history of medication use, medical treatment, or medical/cosmetic procedures that may affect the study results 3. Subjects with a history of severe hypersensitivity or allergy to drugs, cosmetics, or related products 4. Subjects who are pregnant, breastfeeding, or possibly pregnant 5. Subjects who are currently participating in another clinical trial or planning to participate in another clinical trial 6. Subjects who are likely to experience significant changes in living environment or external factors (e.g., ultraviolet exposure) during the study period that may affect the evaluation 7. Subjects who are unable to comply with study procedures or provide adequate cooperation 8. Subjects who are judged by the principal investigator to be unsuitable for participation for any reason

Design outcomes

Primary

MeasureTime frame
Changes in skin color parameters (L* and a* values)

Countries

Japan

Contacts

Public ContactEiko Uno

Rohto Pharmaceutical Co., Ltd. Fundamental Technology Research Department

unoe@rohto.co.jp0774-71-8774

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026